Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.79), $0.17 better than the analyst estimate of ($0.96).

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.